Enhanced capacity of n-3 fatty acid-enriched macrophages to oxidize low density lipoprotein mechanisms and effects of antioxidant vitamins

Atherosclerosis

Volumn 124, Issue 2, 1996, Pages 157-169

  Suzukawa, Michio ^a,b   Abbey, Mavis ^a   Clifton, Peter ^a   Nestel, Paul J ^a  

^a CSIRO   (Australia)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Atherosclerosis; Fish oil; Lipid peroxidation; Low density lipoprotein oxidation; Macrophages

Indexed keywords

5,8,11,14 ICOSATETRAYNOIC ACID; ALPHA TOCOPHEROL; ANTIOXIDANT; FISH OIL; LOW DENSITY LIPOPROTEIN; OMEGA 3 FATTY ACID; UNCLASSIFIED DRUG;

ARTICLE; ATHEROSCLEROSIS; HUMAN; HUMAN CELL; LIPID PEROXIDATION; MACROPHAGE; PRIORITY JOURNAL;

EID: 0030565020     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(96)05818-2     Document Type: Article

References (51)

1. [1] Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modification of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915.
2. [2] Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991;88:1785.
3. [3] Steinbrecher UP, Zhang H, Lougheed M. Role of oxidatively modified LDL in atherosclerosis. Free Radical Biol Med 1990;9:155.
4. [4] Steinberg D. Workshop Participants, Antioxidants in the prevention of human atherosclerosis. Summary of the proceedings of a National Heart, Lung and Blood Institute Workshop: September 5-6, 1991, Bethesda, Maryland. Circulation 1992;85:2338.
5. [5] Parthasarathy S, Wieland E, Steinberg D. A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein. Proc Natl Acad Sci USA 1989;86:1046.
6. [6] Heinecke JW, Baker L, Rosen H, Chait A. Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells. J Clin Invest 1986;77:757.
7. [7] Rankin SM, Parthasarathy S, Steinberg D. Evidence for a dominant role of lipoxygenase(s) in the oxidation of LDL by mouse peritoneal macrophages. J Lipid Res 1991;32:449.
8. [8] Lynch SM, Frei B. Mechanisms of copper- and iron-dependent oxidative modification of human low density lipoprotein. J Lipid Res 1993;34:1745.
9. [9] Aqel NM, Ball RY, Waldmann H, Mitchinson MJ. Monocytic origin of foam cells in human atherosclerotic plaques. Atherosclerosis 1984;53:265.
10. [10] Parthasarathy S, Steinberg D. Cell-induced oxidation of LDL. Curr Opin Lipidol 1992;3:313.
11. [11] Regnstrom J, Nilsson J, Tornvall P, Landou C, Hamsten A. Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet 1992;339:1183.
12. [12] Verlangieri AJ, Bush MJ. Effects of d-α-tocopherol supplementation on experimentally induced primate atherosclerosis. J Am Coll Nutr 1992;11:131.
13. [13] Kita T, Nagano Y, Yokode M, Ishii K, Kume N, Ooshima A. Yoshida H, Kawai C. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci USA 1987;84:5928.
14. [14] Stampfer MJ, Charles HH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993;328:1444.
15. [15] Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993;328:1450.
16. [16] Suzukawa M, Abbey M, Clifton P, Nestel PJ. Effects of supplementing with vitamin E on the uptake of low density lipoprotein and the stimulation of cholesteryl ester formation in macrophages. Atherosclerosis 1994;110:77.
17. [17] Parthasarathy S. Evidence for an additional intracellular site of action of probucol in the prevention of oxidative modification of low density lipoprotein. Use of a new water-soluble probucol derivative. J Clin Invest 1992;89:1618.
18. [18] Aviram M, Rosenblat M, Macrophage-mediated oxidation of extracellular low density lipoprotein requires an initial binding of the lipoprotein to its receptor. J Lipid Res 1994;35:385.
19. [19] Leake DS, Rankin SM. The oxidative modification of low-density lipoproteins by macrophages. Biochem J 1990;270:741.
20. [20] Suzukawa M, Abbey M, Howe PRC, Nestel PJ. Effects of fish oil fatty acids on low density lipoprotein size, oxidizability and uptake by macrophages. J Lipid Res 1995;36:473.
21. [21] Chung BH, Segrest JP, Ray MJ, Brunzell JD, Hokanson JE, Krauss RM, Beaudrie K, Cone JT. Single vertical spin gradient ultracentrifugation. Methods Enzymol 1986;128:181.
22. [22] Barter PJ, Jones ME. Rate of exchange of esterified cholesterol between human plasma and high density lipoproteins. Atherosclerosis 1979;34:67.
23. [23] Clifton PM, Chang L, Mackinnon AM. Development of an automated Lowry protein assay for the Cobas-Bio centrifugal analyzer. Anal Biochem 1988;172:165.
24. [24] Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978;52:302.
25. [25] Abbey M, Clifton P, Kestin M, Belling B, Nestel P. Effect of fish oil on lipoproteins, lecithin:cholesterol acyltransferase, and lipid transfer protein activity in humans. Arteriosclerosis 1990;10:85.
26. [26] Sparrow CP, Olszewski J. Cellular oxidative modification of low density lipoprotein dose not require lipoxygenases. Proc Natl Acad Sci USA 1992;89:128.
27. [27] Folcik VA, Cathcart MK. Assessment of 5-lipoxygenase involvement in human monocyte-mediated LDL oxidation. J Lipid Res 1993;34:69.
28. [28] Bonanome A, Pagnon A, Biffanti S, Opportune A, Sorgato F, Dorella M, Maiorino M, Ursini F. Effect of dietary monounsaturated and polyunsaturated fatty acids on the susceptibility of plasma low density lipoprotein to oxidative modification. Arterioscler Thromb 1992;12:529.
29. [29] Abbey M, Belling GB, Noakes M, Hirata F, Nestel PJ. Oxidation of low-density lipoproteins: intraindividual variability and the effect of dietary linoleate supplementation. Am J Clin Nutr 1993;57:391.
30. [30] Reaven PD, Parthasarathy S, Grasse BJ, Miller E, Steinberg D, Witztum J. Effects of oleate-rich and linoleaterich diets on the susceptibility of low density lipoprotein to oxidative modification in mildly hypercholesterolemic subjects. J Clin Invest 1993;91:668.
31. [31] Lussier-Cacan S, Dubreuil-Quidoz S, Roederer G, Leboeuf N, Boulet L, de Langavant GC, Davignon J, Naruszewicz M. Influence of probucol on enhanced LDL oxidation after fish oil treatment of hypertriglyceridemic patients. Arterioscler Thromb 1993;13:1790.
32. [32] Harats D, Dabach Y, Hollander G, Ben-Naim M, Schwartz R, Berry EM, Stein O, Stein Y. Fish oil ingestion in smokers and non-smokers enhances peroxidation of plasma lipoproteins. Atherosclerosis 1991;90:127.
33. [33] von Schacky C, Fischer S, Weber PC. Long-term effects of dietary marine ω-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans. J Clin Invest 1985;76:1626.
34. [34] Lee TH, Hoover RL, Williams JD, Sperling RI, Ravalese J III, Spur BW, Rovinson DR, Corey EJ, Lewis RA, Austen KF. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med 1985;312:1217.
35. [35] Lokesh BR, German B, Kinsella JE. Differential effects of docosahexaenoic acid and eicosapentaenoic acid on suppression of lipoxygenase pathway in peritoneal macrophages. Biochim Biophys Acta 1988;958:99.
36. [36] Cathcart MK, McNally AK, Chisolm GM. Lipoxygenase mediated transformation of human low density lipoprotein to an oxidized and cytotoxic complex. J Lipid Res 1991;32:63.
37. [37] Rankin SM, Parthasarathy S, Steinberg D. Evidence for a dominant role of lipoxygenase(s) in the oxidation of LDL by mouse peritoneal macrophages. J Lipid Res 1991;32:449.
38. [38] Hiramatsu K, Rossen H, Heinecke JW, Wolfbauer G, Chait A. Superoxide initiates oxidation of low density lipoprotein by human monocytes. Arteriosclerosis 1987;7:55.
39. [39] Yla-Hertuala S, Rosenfeld ME, Parthasarathy S, Glass, C.K., Sigal E, Witztum JL, Steinberg D. Colocalization of 15-lipoxygenase messenger RNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc Natl Acad Sci USA 1990;87:6959.
40. [40] Kühn H, Belkner J, Suzuki H, Yamamoto S. Oxidative modification of human lipoproteins by lipoxygenases of different positional specificities. J Lipid Res 1994;35:1749.
41. [41] Fisher M, Levine PH, Weiner BH, Johnson MH, Doyle EM, Elis PA, Hoogasian JJ. Dietary n-3 fatty acid supplementation reduces superoxide production and chemiluminescence in a monocyte-enriched preparation of leukocytes. Am J Clin Nutr 1990;51:804.
42. [42] Jessup W, Simpson JA, Dean RT. Dose superoxide radical have a role in macrophage-mediated oxidative modification of LDL? Atherosclerosis 1993;99:107.
43. [43] Burns CP, Wagner BA. Heightened susceptibility of fish oil polyunsaturate-enriched neoplastic cells to ethane generation during lipid peroxidation. J Lipid Res 1991;32:79.
44. [44] Alexander-North L, North JA, Kiminyo KP. Buettner GR, Spector AA. Polyunsaturated fatty acids increase lipid radical formation induced by oxidant stress in endothelial cells. J Lipid Res 1994;35:1773.
45. [45] O'Leary VJ, Darley-Usmar VM, Russell LJ, Stone D. Prooxidant effects of lipoxygenase-derived peroxides on the copper-initiated oxidation of low-density lipoprotein. Biochem J 1992;282:631.
46. [46] Oostenbrug GS, Mensink RP, Hornstra G. A moderate in vivo vitamin E supplement counteracts the fish-oil-induced increase in in-vitro oxidation of human low-density lipoproteins. Am J Clin Nutr 1993;57(suppl):8275.
47. [47] Traber MG, Kayden HJ. Tocopherol distribution and intracellular localization in human adipose tissue. Am J Clin Nutr 1987;46:488.
48. [48] Kardinaal AFM, Kok FJ, Ringstad J, Gomez-Aracena J, Mazaev VP, Kohlmeier L, Martin BC, Aro A, Kark JD, Delgado-Rodribuez M, Riemersma RA, van't Veer P, Huttunen JK, Martin-Moreno JM. Antioxidants in adipose tissue and risk of myocardial infarction: the EURAMIC study. Lancet 1993;342:1379.
49. [49] Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA 1989;86:6377.
50. [50] Food and Nutrition board. "Recommended Dietary Allowances", 10th ed. Washington, DC: National Research Council, National Academy Press, 1989.
51. [51] Muggli R. Physiological requirement of vitamin E as a function of the amount and type of polyunsaturated fatty acid. World Rev Nutr Diet 1994;75:166.